Article Information
History
- April 1, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Shijian Zhang1,*,
- Eden P. Go2,*,
- Haitao Ding3,
- Saumya Anang1,
- John C. Kappes3,4,
- Heather Desaire2 and
- Joseph Sodroski1,5,**
- 1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Department of Microbiology, Harvard Medical School, Boston, MA 02215, USA
- 2Department of Chemistry, University of Kansas, Lawrence, KS 66049, USA
- 3Department of Medicine, University of Alabama at Birmingham, AL 35294, USA
- 4Birmingham Veterans Affairs Medical Center, Research Service, Birmingham, AL 35233, USA
- 5Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA
- ↵**Corresponding author: Joseph G. Sodroski, M.D., Dana-Farber Cancer Institute, 450 Brookline Avenue, CLS 1010, Boston, MA 02215, Phone: 617-632-3371, Fax: 617-632-4338, Email: joseph_sodroski{at}dfci.harvard.edu
↵* These authors contributed equally to the research reported in this manuscript.
Posted April 01, 2021.
Analysis of glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein
